公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | Factors associated with adherence to low-tidal volume strategy for acute lung injury and acute respiratory distress syndrome and their impacts on outcomes: An observational study and propensity analysis | YEN-FU CHEN ; Lim C.-K.; SHENG-YUAN RUAN ; JIH-SHUIN JERNG ; JOU-WEI LIN ; PING-HUNG KUO ; HUEY-DONG WU ; CHONG-JEN YU | Minerva Anestesiologica | 19 | 17 | |
2013 | Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease | MENG-RUI LEE ; CHING-YAO YANG ; Chang K.-P.; LI-TA KENG ; Yen D.H.-T.; JANN-YUAN WANG ; HUEY-DONG WU ; LI-NA LEE ; CHONG-JEN YU | PLoS ONE | 26 | 22 | |
2015 | Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination | MENG-RUI LEE ; Yang C.-Y.; CHIN-CHUNG SHU ; CHING-KAI LIN ; Wen Y.-F.; Lee S.-W.; JEN-CHUNG KO ; JANN-YUAN WANG ; LI-NA LEE ; CHONG-JEN YU | Clinical Microbiology and Infection | 22 | 18 | |
2009 | Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis | JANN-YUAN WANG ; LI-NA LEE ; CHONG-JEN YU ; Chien Y.-J.; PAN-CHYR YANG | Respirology | 47 | 49 | |
2009 | Factors influencing visibility and diagnostic yield of transbronchial biopsy using endobronchial ultrasound in peripheral pulmonary lesions | CHUN-TA HUANG ; CHAO-CHI HO ; Tsai Y.-J.; CHONG-JEN YU ; PAN-CHYR YANG | Respirology | 95 | 87 | |
2016 | Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease | Chang C.-H.; Chuang L.-P.; Lin S.-W.; Lee C.-S.; Tsai Y.-H.; Wei Y.-F.; Cheng S.-L.; Hsu J.-Y.; PING-HUNG KUO ; CHONG-JEN YU ; Chen N.-H. | BMC Pulmonary Medicine | 35 | 31 | |
2010 | Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations | KUEI-PIN CHUNG ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Clinical Oncology | 10 | 8 | |
2020 | Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC | Nishio M.; Felip E.; Orlov S.; Park K.; CHONG-JEN YU ; Tsai C.-M.; Cobo M.; McKeage M.; Su W.-C.; Mok T.; Scagliotti G.V.; Spigel D.R.; Viraswami-Appanna K.; Chen Z.; Passos V.Q.; Shaw A.T. | Journal of Thoracic Oncology | 26 | 19 | |
2008 | First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer | Wu J.-Y.; CHONG-JEN YU ; CHIH-HSIN YANG ; SHANG-GIN WU ; Chiu Y.-H.; Gow C.-H.; YEUN-CHUNG CHANG ; Hsu Y.-C.; Wei P.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 69 | 62 | |
2017 | First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study | Soria J.-C.; Tan D.S.W.; Chiari R.; Wu Y.-L.; Paz-Ares L.; Wolf J.; Geater S.L.; Orlov S.; Cortinovis D.; CHONG-JEN YU ; Hochmair M.; Cortot A.B.; Tsai C.-M.; Moro-Sibilot D.; Campelo R.G.; McCulloch T.; Sen P.; Dugan M.; Pantano S.; Branle F.; Massacesi C.; de Castro G.; Jr | The Lancet | 949 | 771 | |
2016 | First-line erlotinib therapy until and beyond response evaluation criteria in solid tumors progression in Asian patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer the ASPIRATION study | Park K.; CHONG-JEN YU ; Kim S.-W.; Lin M.-C.; Sriuranpong V.; Tsai C.-M.; Lee J.-S.; Kang J.-H.; Chan K.C.A.; Perez-Moreno P.; Button P.; Ahn M.-J.; Mok T. | JAMA Oncology | 200 | 164 | |
2023 | First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial | Kim, Hye Ryun; Sugawara, Shunichi; Lee, Jong-Seok; Kang, Jin-Hyoung; Inui, Naoki; Hida, Toyoaki; Lee, Ki Hyeong; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Nishio, Makoto; Ohe, Yuichiro; Tamura, Tomohide; Yamamoto, Nobuyuki; CHONG-JEN YU ; Akamatsu, Hiroaki; Takahashi, Shigeru; Nakagawa, Kazuhiko | Cancer medicine | 1 | 0 | |
2007 | Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: Associated genetic mutations and relationship to antimicrobial exposure | JANN-YUAN WANG ; LI-NA LEE ; HSIN-CHIH LAI ; Wang S.-K.; I-SHIOW JAN ; CHONG-JEN YU ; PO-REN HSUEH ; PAN-CHYR YANG | Journal of Antimicrobial Chemotherapy | 120 | 111 | |
2013 | Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis | SHANG-GIN WU ; Hu F.-C.; YIH-LEONG CHANG ; Lee Y.-C.; CHONG-JEN YU ; YEUN-CHUNG CHANG ; Wu J.-Y.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 35 | 36 | |
2008 | Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma | SHANG-GIN WU ; Gow C.-H.; CHONG-JEN YU ; YIH-LEONG CHANG ; CHIH-HSIN YANG ; Hsu Y.-C.; JIN-YUAN SHIH ; Lee Y.-C.; PAN-CHYR YANG | European Respiratory Journal | 109 | 95 | |
2020 | Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma | Lu, Hsuan-Hsuan; SHU-YUNG LIN ; Weng, Rueyhung Roc; Juan, Yi-Hsiu; Chen, Yen-Wei; HSIN-HAN HOU ; Hung, Zheng-Ci; Oswita, Giovanni Audrey; Huang, Yi-Jhen; Guu, Shih-Yun; Khoo, Kay-Hooi; JIN-YUAN SHIH ; CHONG-JEN YU ; HSING-CHEN TSAI | EBioMedicine | 21 | 15 | |
2013 | Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer | Chen C.-Y.; Jan Y.-H.; Juan Y.-H.; Yang C.-J.; Huang M.-S.; CHONG-JEN YU ; PAN-CHYR YANG ; Hsiao M.; Hsu T.-L.; Wong C.-H. | Proceedings of the National Academy of Sciences of the United States of America | 215 | 189 | |
2020 | Gastrointestinal complications are associated with a poor outcome in non-critically ill pneumonia patients | CHUN-TA HUANG ; CHUN-MING HONG ; Tsai Y.-J.; WANG-HUEI SHENG ; CHONG-JEN YU | BMC Gastroenterology | 3 | 2 | |
2017 | Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan | LIH-YU CHANG ; Lee C.-H.; JEN-CHANG KO ; Chang L.-Y.; Lee M.-C.; JANN-YUAN WANG ; CHONG-JEN YU | Cancer Medicine | 8 | 7 | |
2011 | Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations | Wu J.-Y.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Medicine | 32 | 27 | |